Literature DB >> 7046595

Distribution of antileukoprotease in upper respiratory mucosa.

U Fryksmark, K Ohlsson, A Polling, H Tegner.   

Abstract

Human respiratory tract secretions contain enzyme inhibitors derived from plasma and a low molecular weight, acid-stable protease inhibitor, antileukoprotease. The distribution of antileukoprotease in normal upper respiratory tract mucosa has been studied using an immunohistologic technique. The inhibitor was localized to the serous parts of the submucosal glands of the maxillary sinus and the trachea but was not demonstrable in mucous glands and goblet cells. It is concluded that the antileukoprotease found in respiratory tract secretions is produced locally in the submucosal serous glands.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7046595     DOI: 10.1177/000348948209100308

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  15 in total

1.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonic mucosa.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

3.  The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.

Authors:  Aileen Gibbons; Danielle Padilla-Carlin; Ciara Kelly; Anthony J Hickey; Clifford Taggart; Noel G McElvaney; Sally-Ann Cryan
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

4.  Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Authors:  C Vogelmeier; R C Hubbard; G A Fells; H P Schnebli; R C Thompson; H Fritz; R G Crystal
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

5.  Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor.

Authors:  M Bohe; C G Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

6.  Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity.

Authors:  M Linden; L Håkansson; K Ohlsson; K Sjödin; H Tegner; A Tunek; P Venge
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

Review 7.  Endogenous regulation of the acute inflammatory response.

Authors:  Peter A Ward; Alex B Lentsch
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells.

Authors:  M Bohe; A Borgström; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

9.  Pancreatic secretory trypsin inhibitor in human Brunner's glands.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

10.  Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

Authors:  M Maruyama; J G Hay; K Yoshimura; C S Chu; R G Crystal
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.